Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder

por Levada, Oleg A., Troyan, Alexandra S.
Publicado 2017

Poststroke Depression Biomarkers: A Narrative Review

por Levada, Oleg A., Troyan, Alexandra S.
Publicado 2018

The Diagnostic Value of the Combination of Serum Brain-Derived Neurotrophic Factor and Insulin-Like Growth Factor-1 for Major Depressive Disorder Diagnosis and Treatment Efficacy

por Troyan, Alexandra S., Levada, Oleg A.
Publicado 2020

Neuropsychiatric Symptoms in Patients with the Main Etiological Types of Mild Neurocognitive Disorders: A Hospital-Based Case–Control Study

por Levada, Oleg A., Cherednichenko, Nataliya V., Troyan, Alexandra S.
Publicado 2017

Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label vortioxetine st...

por Levada, Oleg A., Troyan, Alexandra S., Pinchuk, Irina Y.
Publicado 2020

Plasma Brain-Derived Neurotrophic Factor as a Biomarker for the Main Types of Mild Neurocognitive Disorders and Treatment Efficacy: A Preliminary Study

por Levada, Oleg A., Cherednichenko, Nataliya V., Trailin, Andriy V., Troyan, Alexandra S.
Publicado 2016